MEDICINA
Departamento
Juan Pablo
Horcajada Gallego
Publicaciones en las que colabora con Juan Pablo Horcajada Gallego (16)
2020
-
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536
2017
-
Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme
PLoS ONE, Vol. 12, Núm. 3
2016
-
High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study
Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307
2015
-
Risk factors for severe sepsis in community-onset bacteraemic urinary tract infection: Impact of antimicrobial resistance in a large hospitalised cohort
Journal of Infection, Vol. 70, Núm. 3, pp. 247-254
2014
-
Predictive factors of severe multilobar pneumonia and shock in patients with influenza
Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307
2013
-
Risk factors and effectiveness of preventive measures against influenza in the community
Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183
2012
-
Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization
Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439
-
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study
BMC Infectious Diseases, Vol. 12
-
Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745
-
Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 1
-
Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH
Farmacia Hospitalaria, Vol. 36, Núm. 1
2011
-
Programs to optimize antimicrobial use (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document
Medicina Preventiva, Vol. 17, Núm. 3, pp. 29-39
2010
-
Clinical features of infections and colonization by Acinetobacter genospecies 3
Journal of Clinical Microbiology, Vol. 48, Núm. 12, pp. 4623-4626
2008
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092
2004
-
Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals
Infection Control and Hospital Epidemiology, Vol. 25, Núm. 10, pp. 819-824
-
Type 1 Integrons in Epidemiologically Unrelated Acinetobacter baumannii Isolates Collected at Spanish Hospitals [3]
Antimicrobial Agents and Chemotherapy